PharmSync
ActiveSummary
PharmSync has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €104,589 and a net result of €57,846. Its solvency ranks better than 79% of 13,365 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Directors
Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.